Two of Australia’s leading experts in macular research – Professor Robyn Guymer AM and Associate Professor Zhichao Wu from the Centre for Eye Research Australia (CERA) – will headline an event in November exploring the latest advances in understanding and managing geographic atrophy (GA).
GA is a leading cause of irreversible vision loss in age-related macular degeneration (AMD).
The CPD education event – Filling the Blind Spots: New Perspectives in Geographic Atrophy – is hosted by Astellas Pharma and will be held on November 6 at CERA’s Seminar Room, Level 10, 200 Victoria Parade, Melbourne.
Interested optometrists and eyecare professionals can also participate online.
Astellas Pharma said Prof Guyner and A/Prof Wu would share insights from cutting-edge research into advances in multimodal imaging that are transforming how clinicians identify, monitor, and manage GA in practice.
Participants will also hear about:
- Updates on best practice standards for diagnosis, including how to interpret OCT and fundus autofluorescence findings for accurate staging and progression monitoring.
- Practical guidance to support timely detection and referral, ensuring patients have access to emerging treatment options.
- A deeper understanding of the role of the complement pathway in the pathogenesis of GA and how novel inhibitors may impact the treatment landscape.
Those keen to know more can contact michelle.waugh@astellas.com or register at https://ow.ly/Qm4950XcQbb.
